© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
This channel has partnered with the Brighteon Store and receives a small commission from all sales generated from an affiliate link.
Click the shop now button below to help out this channel.
https://gnews.org/articles/478679
Summary：Kaiser Permanente, a leading insurance company and healthcare provider, commissioned a study to evaluate the efficacy of the mRNA vaccines against the Omicron variant of the CCP Virus. The study revealed that those who received three doses were more likely to get infected. More alarmingly, most of them tend to develop severe illnesses and die after infection
Inside the eight-figure plan to build data centers despite moratoriums
Germany’s ruling coalition pushes to outlaw its biggest opposition party
Iranian Flights to Turkiye, East Asia Continue Despite U.S.-Led Air Restrictions, Tehran Says
Saudi Arabia Restarts East-West Pipeline, Bypassing Strait of Hormuz
Iran’s Parliament Fast-Tracks Bill to Withdraw Tehran From Non-Proliferation Treaty
Netanyahu Defends Israel at UN as Delegates Walk Out; ICC Warrant Looms
